Archives of Medical Research最新文献

{"title":"Effect of Rosmarinic Acid on Cell Proliferation, Oxidative Stress, and Apoptosis Pathways in an Animal Model of Induced Glioblastoma Multiforme","authors":"Sepideh Khaksar ,&nbsp;Khadijeh Kiarostami ,&nbsp;Mahmoud Ramdan","doi":"10.1016/j.arcmed.2024.103005","DOIUrl":"https://doi.org/10.1016/j.arcmed.2024.103005","url":null,"abstract":"<div><h3>Background</h3><p>In brain tumors, the complexity of the pathophysiological processes such as oxidative stress, cell proliferation, angiogenesis, and apoptosis have seriously challenged the definitive treatment. Rosmarinic acid (RA), as a polyphenolic compound, has been found to prevent tumor progression in some aggressive cancers. This study was designed to evaluate the anticancer effects of RA on brain tumors.</p></div><div><h3>Method</h3><p>Rats were divided into six groups. Implantation of C6 glioma cells was carried out in the caudate nucleus of the right hemisphere. RA at doses of 5, 10, and 20 mg/kg (i.p.) was administered to the treatment groups for seven days. Tumor volume (by MRI imaging), locomotor ability, survival time, histological alterations (by H &amp; E staining), expression of <em>p53</em> and <em>p21</em> mRNAs (by RT-PCR), activities of antioxidant enzymes (superoxide dismutase [SOD] and catalase [CAT] by assay kits), expression of caspase-3 and VEGF (by immunohistochemical analysis), and TUNEL-positive cells (by tunnel staining) were analyzed.</p></div><div><h3>Results</h3><p>The results indicated that the RA at a dose of 20 mg/kg reduced the tumor volume, prolonged survival time, increased <em>p53</em> and <em>p21</em> mRNAs, attenuated SOD and CAT activities in tumor tissue, elevated caspase-3, and increased the number of TUNEL-positive cells. Furthermore, histological analysis revealed less invasion of tumor cells into the normal parenchyma in rats treated with RA (20 mg/kg).</p></div><div><h3>Conclusion</h3><p>These findings provide evidence that the ability of RA to reduce tumor volume could be related to factors that modulate oxidative stress (SOD and CAT enzymes), cell proliferation (<em>p53</em> and <em>p21</em>), and apoptosis (caspase-3).</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 4","pages":"Article 103005"},"PeriodicalIF":7.7,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140951284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Late-in-life Exercise Ameliorates the Aging Trajectory Metabolism Programmed by Maternal Obesity in Rats: It is Never Too Late","authors":"Claudia J. Bautista ,&nbsp;Luis A. Reyes-Castro ,&nbsp;Consuelo Lomas-Soria ,&nbsp;Carlos A. Ibáñez ,&nbsp;Elena Zambrano","doi":"10.1016/j.arcmed.2024.103002","DOIUrl":"https://doi.org/10.1016/j.arcmed.2024.103002","url":null,"abstract":"<div><h3>Background</h3><p>Maternal obesity (MO) has been shown to adversely affect metabolic, oxidative, reproductive, and cognitive function in offspring. However, it is unclear whether lifestyle modification can ameliorate the metabolic and organ dysfunction programmed by MO and prevent the effects of metabolic syndrome in adulthood. This study aimed to evaluate whether moderate voluntary exercise in the offspring of rats born to obese mothers can ameliorate the adverse effects of MO programming on metabolism and liver function in mid-adulthood.</p></div><div><h3>Methods</h3><p>Offspring of control (CF1) and MOF1 mothers were fed with a control diet from weaning. Adult males and females participated in 15 min exercise sessions five days/week. Metabolic parameters were analyzed before and after the exercise intervention. Liver oxidative stress biomarkers and antioxidant enzymes were analyzed before and after the intervention.</p></div><div><h3>Results</h3><p>Males showed that CF1_ex ran more than MOF1_ex and increased the distance covered. In contrast, females in both groups ran similar distances and remained constant but ran more distance than males. At PND 300 and 450, male and female MOF1 had higher leptin, triglycerides, insulin, and HOMA-IR levels than CF1. However, male MOF1_ex had lower triglycerides, insulin, and HOMA-IR levels than MOF1. Improvements in liver fat and antioxidant enzymes were observed in CF1_ex and MOF1_ex males and females compared to their respective CF1 and MOF1 groups.</p></div><div><h3>Conclusion</h3><p>These findings suggest that moderate voluntary exercise, even when started in mid-adulthood, can improve metabolic outcomes and delay accelerated metabolic aging in MO-programmed rats in a sex-dependent manner.</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 4","pages":"Article 103002"},"PeriodicalIF":7.7,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140910290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Presymptomatic Testing for Huntington's Disease in Mexico: 28 Years of Experience","authors":"Adriana Ochoa-Morales ,&nbsp;David José Dávila-Ortiz de Montellano ,&nbsp;Mireya Chávez-Oliveros ,&nbsp;Yaneth Rodríguez-Agudelo ,&nbsp;Mariana Longoria-Ibarrola ,&nbsp;Ana Luisa Sosa-Ortiz ,&nbsp;Marie-Catherine Boll ,&nbsp;Aurelio Jara-Prado ,&nbsp;Petra Yescas-Gómez ,&nbsp;Jorge Guerrero-Camacho ,&nbsp;Miguel Ángel Ramírez-García","doi":"10.1016/j.arcmed.2024.103004","DOIUrl":"https://doi.org/10.1016/j.arcmed.2024.103004","url":null,"abstract":"<div><h3>Introduction</h3><p>Huntington's disease (HD) is a genetic neurodegenerative disorder with dominant inheritance. Our center in Mexico City has offered presymptomatic testing (PT) since 1995.</p></div><div><h3>Objective</h3><p>To describe the main clinical and demographic characteristics of at-risk HD individuals who applied to the PT program, the reasons for seeking it, and the molecular results.</p></div><div><h3>Methods</h3><p>A cross-sectional study was conducted with sociodemographic and clinical data of all PT applicants from 1995–2023. Reasons for seeking PT were assessed using a modified questionnaire. In addition, anxiety, and depressive symptoms before and after PT were evaluated with Beck's instruments; cognitive impairment (CI) was assessed with the Mini-Mental State Examination (MMSE) and molecular results.</p></div><div><h3>Results</h3><p>214 people applied for PT (2.1% of the at-risk population identified in our center); 63% were women (mean age of 37.11 years). 204 (95.3%) were accepted and 190 received results. 70% indicated that the main reason for applying for PT was to inform their offspring about the risk of inheriting HD. Significant differences were observed in the reasons for seeking PT by age group. Although some subjects received treatment, Beck's instrument scores did not indicate special attention or pharmacological treatment. The MMSE showed probable CI in 20 subjects. Of those who received results, 37% were carriers of a full penetrance allele.</p></div><div><h3>Conclusion</h3><p>Our center has the only formal PT program for HD in Mexico. The reasons for seeking PT are varied and age-related. Although PT is offered to all subjects at risk for HD, uptake remains low.</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 4","pages":"Article 103004"},"PeriodicalIF":7.7,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140843042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnosis and Treatment of Pituitary Apoplexy, A True Endocrine Emergency","authors":"Alberto Moscona-Nissan,&nbsp;Jessica Sidauy-Adissi,&nbsp;Karla Ximena Hermoso-Mier,&nbsp;Shimon Shlomo Glick-Betech,&nbsp;Leonel de Jesús Chávez-Vera,&nbsp;Florencia Martinez-Mendoza,&nbsp;Oscar Mario Delgado-Casillas,&nbsp;Keiko Taniguchi-Ponciano,&nbsp;Daniel Marrero-Rodríguez,&nbsp;Moisés Mercado","doi":"10.1016/j.arcmed.2024.103001","DOIUrl":"https://doi.org/10.1016/j.arcmed.2024.103001","url":null,"abstract":"<div><p>Pituitary apoplexy (PA) is a clinical syndrome resulting from a hemorrhagic infarction of the pituitary gland. It is characterized by the sudden onset of visual disturbances, nausea, vomiting, headache and occasionally, signs of meningeal irritation and an altered mental status. The exact pathogenesis of PA remains to be elucidated, although tumor overgrowth of its blood supply remains the most popular theory. Main risk factors for the development of PA include systemic, iatrogenic, and external factors as well as the presence of an underlying pituitary tumor. The diagnostic approach of PA includes both neuroimaging and evaluation of pituitary secretory function.</p><p>PA is a potentially life-threatening condition which should be managed with hemodynamic stabilization, correction of electrolyte abnormalities and replacement of hormonal deficiencies. PA treatment should be individualized based on the severity of the clinical picture which may vary widely. Treatment options include conservative management with periodic follow-up or neurosurgical intervention, which should be decided by a multidisciplinary team. We conducted a systematic review of the literature to unveil the frequency of PA predisposing factors, clinical and biochemical presentations, management strategies and outcomes.</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 4","pages":"Article 103001"},"PeriodicalIF":7.7,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140825864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Metformin Improves Sarcopenia-Related Quality of Life in Geriatric Adults: A Randomized Controlled Trial","authors":"Rizwan Qaisar ,&nbsp;Asima Karim ,&nbsp;Tahir Muhammad ,&nbsp;M. Shahid Iqbal ,&nbsp;Firdos Ahmad","doi":"10.1016/j.arcmed.2024.102998","DOIUrl":"https://doi.org/10.1016/j.arcmed.2024.102998","url":null,"abstract":"<div><h3>Objectives</h3><p>Metformin protects against age-related muscle decline, termed sarcopenia. However, the effects on sarcopenia quality-of-life (SarQoL) are unknown. We investigated the effects of metformin on SarQoL and associated mechanisms in older adults.</p></div><div><h3>Method</h3><p>This double-blind randomized, placebo-controlled trial included geriatric adult men, divided into non-sarcopenic controls (age = 72.2 ± 4.3 years, <em>n</em> = 52) and two groups of patients with sarcopenia randomized into placebo (age at baseline = 74.4 ± 5.7 years, <em>n</em> = 54) and metformin (age at baseline = 71.2 ± 3.9 years, <em>n</em> = 47) groups. Patients in the metformin group received 1.7 grams twice daily for four months. We evaluated SarQoL, handgrip strength (HGS), plasma zonulin, c-reactive protein (CRP), and 8-isoprostanes.</p></div><div><h3>Results</h3><p>Patients with sarcopenia had lower HGS and SarQoL than controls (both <em>p</em> &lt;0.05). Metformin improved the HGS and the SarQoL domains related to physical and mental health, locomotion, and leisure activities, as well as cumulative SarQoL scores (all <em>p</em> &lt;0.05). Metformin also prevented the decline in the SarQoL domains for functionality and fear. Among plasma biomarkers, metformin reduced the levels of zonulin, CRP, 8-isoprostanes, and creatine kinase. We also found a significant correlation of plasma zonulin with cumulative SarQoL in patients with sarcopenia taking metformin, suggesting a role for intestinal repair in improving SarQoL. Finally, metformin did not affect body composition and gait speed.</p></div><div><h3>Conclusion</h3><p>Overall, metformin improved HGS and SarQoL by repairing intestinal leakage. Our data have clinical relevance for improving the quality of life in older adults with sarcopenia.</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 4","pages":"Article 102998"},"PeriodicalIF":7.7,"publicationDate":"2024-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140551347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Motor, Cognitive, and Behavioral Impairment in TLR3 and TLR9 Deficient Male Mice: Insights into the Non-Immunological Roles of Toll-Like Receptors","authors":"Héctor Vargas-Calderón ,&nbsp;Emmanuel Ortega-Robles ,&nbsp;Luisa Rocha ,&nbsp;Philipp Yu ,&nbsp;Oscar Arias-Carrión","doi":"10.1016/j.arcmed.2024.102985","DOIUrl":"https://doi.org/10.1016/j.arcmed.2024.102985","url":null,"abstract":"<div><h3>Background</h3><p>Toll-like receptors (TLRs) play a critical role in initiating the innate immune response to infection or injury. Recent studies have uncovered their intriguing functions as moonlighting proteins involved in various biological processes, including development, learning, and memory. However, the specific functions of individual TLRs are still largely unknown.</p></div><div><h3>Aims</h3><p>We investigated the effects of TLR3 and TLR9 receptor deficiency on motor, cognitive, and behavioral functions during development using genetically modified male mice of different ages.</p></div><div><h3>Methods</h3><p>We evaluated the motor coordination, anxiety-like behavior, spatial learning, and working memory of male mice lacking the TLR3 and TLR9 genes at different ages (two, four, six, and eight months) using the rotarod, open field, water maze, and T-maze tests.</p></div><div><h3>Results</h3><p>We observed that the deletion of either TLR3 or TLR9 resulted in impaired motor performance. Furthermore, young TLR3-deficient mice exhibited reduced anxiety-like behavior and spatial learning deficits; however, their working memory was unaffected. In contrast, young TLR9-knockout mice showed hyperactivity and a tendency toward decreased working memory.</p></div><div><h3>Conclusions</h3><p>These findings provide valuable insights into the broader roles of the TLR system beyond the innate immune response, revealing its involvement in pathways associated with the central nervous system. Importantly, our results establish a strong association between the endosomal receptors TLR3 and TLR9 and the performance of motor, cognitive, and behavioral tasks that change over time. This study contributes to the growing body of research on the multifaceted functions of TLRs and enhances our understanding of their participation in non-immune-related processes.</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 3","pages":"Article 102985"},"PeriodicalIF":7.7,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140191732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Screening the General Population for Non-Alcoholic Fatty Liver Disease: Model Development and Validation","authors":"Tanya Mohammadi ,&nbsp;Babak Mohammadi","doi":"10.1016/j.arcmed.2024.102987","DOIUrl":"https://doi.org/10.1016/j.arcmed.2024.102987","url":null,"abstract":"<div><h3>Background</h3><p>The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide. Screening the general population for this may help to select appropriate diagnostic and preventive measures before disease progression.</p></div><div><h3>Aims</h3><p>We aimed to develop a screening method to identify patients with NAFLD in the general population.</p></div><div><h3>Methods</h3><p>We analyzed cross-sectional data from a large Japanese study of NAFLD. Principal component analysis was used to analyze the data. Candidate predictors were patients’ demographic, clinical, and laboratory characteristics. The resulting model was externally validated using three data sets from different populations.</p></div><div><h3>Results</h3><p>Of 15,464 (54.5% men) included patients, 2,741 (17.7%) had NAFLD as determined by ultrasonography. An index was calculated as the arithmetic mean of the scaled body mass index and serum triglyceride levels for both men and women. The area under the receiver operating characteristic curve, sensitivity, specificity, and false positive rate were 0.875, 0.824, 0.770, and 17.6%, respectively. The mean index values were significantly different between the patients with and without non-alcoholic fatty liver disease (<em>p</em> &lt;0.001). The odds ratio of the index cutoff was 15.6 (95% confidence interval [CI]:14.05, 17.39). The model yielded areas under the curve of 0.828, 0.851, and 0.836 for a Chinese (N = 2,319), an Iranian (N = 2,160), and a Brazilian (N = 45,029) data set, respectively.</p></div><div><h3>Conclusions</h3><p>The proposed composite index demonstrated high performance and generalizability, suggesting its potential use as a screening tool for NAFLD in the general population.</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 3","pages":"Article 102987"},"PeriodicalIF":7.7,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140187281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Biomarkers of Physical and Mental Health for Prediction of Parkinson's Disease: A Population-Based Study from 15 European Countries","authors":"M. Azhar Hussain ,&nbsp;Rizwan Qaisar ,&nbsp;Asima Karim ,&nbsp;Firdos Ahmad ,&nbsp;Fabio Franzese ,&nbsp;Saad M. Alsaad ,&nbsp;Abeer A. Al-Masri ,&nbsp;Shaea A. Alkahtani","doi":"10.1016/j.arcmed.2024.102988","DOIUrl":"https://doi.org/10.1016/j.arcmed.2024.102988","url":null,"abstract":"<div><h3>Objectives</h3><p>Early diagnosis of Parkinson's disease (PD) is critical for optimal treatment. However, the predictive potential of physical and mental health in PD is poorly characterized.</p></div><div><h3>Methods</h3><p>We evaluated the potential of multiple demographic, physical, and mental factors in predicting the future onset of PD in older adults aged 50 years or older from 15 European countries. Individual study participants were followed over four waves of the Survey of Health, Ageing, and Retirement in Europe (SHARE) from 2013–2020.</p></div><div><h3>Results</h3><p>Of 57,980 study participants, 442 developed PD during the study period. We identified male sex and advancing age from the sixth decade of life onward as significant predictors of future PD. Among physical factors, a low handgrip strength (HGS; men &lt;27 kg, women &lt;16 kg), being bothered by frailty, and recent falls were significantly associated with future PD. Among mental factors, a higher depression (Euro-D depression score &gt;6) emerged as an independent predictor of future PD. Finally, the presence of hypertension or Alzheimer's disease (AD) increases the risk of future PD.</p></div><div><h3>Conclusions</h3><p>Altogether, male sex, advancing age, low HGS, frailty, depression, hypertension, and AD were identified as critical risk factors for future PD. Our results may be useful in the early identification and treatment of populations at risk for PD.</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 3","pages":"Article 102988"},"PeriodicalIF":7.7,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140180028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"High Prevalence of Familial Hypercholesterolemia Due to the Founder Effect of the LDLR c.2271del Variant in Communities of Oaxaca, Mexico","authors":"Perla Graciela Rodríguez-Gutiérrez ,&nbsp;Teresita de Jesús Hernández-Flores ,&nbsp;Paola Montserrat Zepeda-Olmos ,&nbsp;Christian Daniel Reyes-Rodríguez ,&nbsp;Kiabeth Robles-Espinoza ,&nbsp;Ulises Solís-Gómez ,&nbsp;Juan Ramón González-García ,&nbsp;María Teresa Magaña-Torres","doi":"10.1016/j.arcmed.2024.102971","DOIUrl":"https://doi.org/10.1016/j.arcmed.2024.102971","url":null,"abstract":"<div><h3>Introduction</h3><p>In Mexico, familial hypercholesterolemia (FH) is underdiagnosed, but population screening in small communities where at least one homozygous patient has already been detected results in a useful and inexpensive approach to reduce this problem. Considering that we previously reported nine homozygous cases from the state of Oaxaca, we decided to perform a population screening to identify patients with FH and to describe both their biochemical and genetic characteristics.</p></div><div><h3>Methods</h3><p>LDL cholesterol (LDLc) was quantified in 2,093 individuals from 11 communities in Oaxaca; either adults with LDLc levels ≥170 mg/dL or children with LDLc ≥130 mg/dL were classified as suggestive of FH and therefore included in the genetic study. <em>LDLR</em> and <em>APOB</em> (547bp fragment of exon 26) genes were screened by sequencing and MLPA analysis.</p></div><div><h3>Results</h3><p>Two hundred and five individuals had suggestive FH, with a mean LDLc of 223 ± 54 mg/dL (range: 131–383 mg/dL). Two pathogenic variants in the <em>LDLR</em> gene were detected in 149 individuals: c.-139_-130del (<em>n</em> = 1) and c.2271del (<em>n</em> = 148). All patients had a heterozygous genotype. With the cascade screening of their relatives (<em>n</em> = 177), 15 heterozygous individuals for the c.2271del variant were identified, presenting a mean LDLc of 133 ± 35 mg/dL (range: 60–168 mg/dL).</p></div><div><h3>Conclusions</h3><p>The FH frequency in this study was 7.8% (164/2093), the highest reported worldwide. A founder effect combined with inbreeding could be responsible for the high percentage of patients with the <em>LDLR</em> c.2271del variant (99.4%), which allowed us to detect both significant biochemical heterogeneity and incomplete penetrance; hence, we assumed the presence of phenotype-modifying variants.</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 3","pages":"Article 102971"},"PeriodicalIF":7.7,"publicationDate":"2024-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140179633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Role of Angiotensin II in Non-Alcoholic Steatosis Development","authors":"Zimri Aziel Alvarado-Ojeda ,&nbsp;Celeste Trejo-Moreno ,&nbsp;Eduardo Ferat-Osorio ,&nbsp;Marisol Méndez-Martínez ,&nbsp;Gladis Fragoso ,&nbsp;Gabriela Rosas-Salgado","doi":"10.1016/j.arcmed.2024.102986","DOIUrl":"https://doi.org/10.1016/j.arcmed.2024.102986","url":null,"abstract":"<div><p>Fatty liver is a multifactorial disease characterized by excessive accumulation of lipids in hepatocytes (steatosis), insulin resistance, oxidative stress, and inflammation. This disease has a major public health impact because it is the first stage of a chronic and degenerative process in the liver that can lead to steatohepatitis, cirrhosis, and liver cancer. Although this disease is mainly diagnosed in patients with obesity, type 2 diabetes mellitus, and dyslipidemia, recent evidence indicates that vasoactive hormones such as angiotensin II (ANGII) not only promote endothelial dysfunction (ED) and hypertension, but also cause fatty liver, increase adipose tissue, and develop a pro-steatotic environment characterized by a low-grade systemic pro-inflammatory and pro-oxidant state, with elevated blood lipid levels. The role of ANGII in lipid accumulation has been little studied, so this review aims to summarize existing reports on the possible mechanism of action of ANGII in inducing lipid accumulation in hepatocytes.</p></div>","PeriodicalId":8318,"journal":{"name":"Archives of Medical Research","volume":"55 3","pages":"Article 102986"},"PeriodicalIF":7.7,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140134398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}